BPC 157 10mg+GHK-CU 50mg+TB500 10mg

Compound Overview

BBG70 is documented as a Nexus-only blend SKU. Its identity is defined by its three listed peptide components and their stated component amounts: BPC-157 10mg, GHK-Cu 50mg, and TB-500 10mg. The product is classified as a multi-peptide blend rather than a single isolated chemical entity.

The structural description provided for this SKU is: blend of BPC-157, GHK-Cu, and TB-500; no single molecular formula or molecular weight applies. That distinction is important for research documentation, receiving logs, sample tracking, and downstream internal records. A blend can be cataloged by product name, SKU, total research size, and component amounts, but it should not be assigned a single CAS number, sequence, formula, or molecular weight unless validated source documentation provides one.

For laboratories evaluating this material, the appropriate interpretation is component-level. BPC-157 is listed in the source data as the pentadecapeptide component, GHK-Cu as the copper tripeptide component, and TB-500 as the thymosin beta-4 component. No additional mechanistic claims, efficacy claims, biological outcomes, or experimental conclusions are provided for the blend in the source record.

Research Background & Published Literature

The supplied research background for BBG70 states that blend identity depends on component amount, purity, and COA data for each component, and that one CAS number, molecular formula, or molecular weight should not be assigned to the blend. No blend-specific citations are included in the provided research data, and no external peer-reviewed literature entries are supplied for this SKU.

Accordingly, this description does not infer blend-specific research outcomes from the names of the individual components. Researchers needing a literature review should treat BPC-157, GHK-Cu, and TB-500 as separate component records and verify any published references against their own laboratory review process. Any discussion of mechanisms, assay models, or biological pathways should be supported by component-specific source material and should remain separate from unsupported claims about the three-component blend.

The source record identifies only one source entry for this item: the raw Nexus catalog. That catalog record supports the SKU, catalog format, component list, classification, physical form, intended use, and storage guidance. It does not support additional claims about therapeutic activity, dosing, human use, veterinary use, treatment, diagnosis, disease prevention, or product performance in any biological system.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Sikiric et al. (2024) — Inflammopharmacology
• Pickart et al. (2012) — Oxid Med Cell Longev
• Goldstein et al. (2005) — Trends Mol Med
• Sosne et al. (2010) — FASEB J

Storage, Handling & Stability Guidelines

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Maintain the lyophilized material under the documented -20°C storage condition until it is needed for a validated laboratory workflow.
• Protect the material from moisture and light during storage and handling.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.
• Use appropriate laboratory PPE and follow institutional chemical handling procedures for research reagents.
• Record product name, SKU, component amounts, reconstitution details, operator initials, and handling dates in internal logs where applicable.

The source record does not specify a post-reconstitution storage temperature, validated beyond-use interval, reconstitution diluent, concentration, or assay-specific preparation protocol. Those details should not be inferred from this product page.

Quality Assurance & Lab Verification

The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.